COVID-19 cases treated with classical homeopathy: a retrospective analysis of International Academy of Classical Homeopathy database
Authors:
- Seema MaheshSMSeema Mahesh
- George VithoulkasGVGeorge Vithoulkas
- International Academy of Classical Homeopathy (IACH) COVID CollaboratorsICInternational Academy of Classical Homeopathy (IACH) COVID Collaborators
Open Access
- 9 June 2023
- journal article
- research article
- Published by International Society of Global Health in Journal of Global Health Reports
- Vol. 7, e2023027
Abstract
Background: The COVID-19 pandemic has posed an unprecedented challenge to global health. Classical homeopathy may have a role to play in alleviating this burden. The objective of this study was to curate data on the treatment effect of classical homeopathy for COVID-19 in a real-world scenario to guide future scientific investigations. Methods: Classical homeopaths from the International Academy of Classical Homeopathy (IACH) were asked to provide details on cases they treated by filling out a standardized questionnaire. COVID-19 cases were defined according to World Health Organization (WHO) criteria as suspected/probable/confirmed cases, with intervention provided being either stand-alone classical homoeopathy or combined with conventional therapy for COVID-19. Cases were followed up with main outcomes being ‘improved’, ‘not improved’ or ‘progressed’ post-treatment. Details of the homeopathic remedies used and main symptoms at the presentation were gathered. Factors associated with main outcomes were investigated with correlational and regression analyses. Results: 367 patients (male 166, female 201) met eligibility criteria (mean age 42.75 years). The mean follow-up period was 6.5 (standard deviation, SD=5.3) days. 255 were confirmed COVID-19 cases, with 61 probable and 51 suspected cases, respectively. The most used remedy was Arsenicum album. Over 73% of COVID-19 patients (and about 79% of severe cases) improved under classical homeopathic treatment. The number of remedies required per individual was negatively correlated to improvement (P< 0.01). Fever, the most common symptom at presentation (74.4%), was associated with an increased likelihood of improvement (PP<0.01). Conclusions: This study suggests that classical homeopathy was associated with improvement in COVID-19, including severe cases. Despite limitations from study design and data sources, our findings should prompt further studies on the role of classical homeopathy in the management of COVID-19.Keywords
This publication has 31 references indexed in Scilit:
- The Experience of an Italian Public Homeopathy Clinic during the COVID-19 Epidemic, March-May 2020Homeopathy, 2020
- Effects of age and sex on recovery from COVID-19: Analysis of 5769 Israeli patientsJournal of Infection, 2020
- COVID and Classical HomeopathyHomœopathic Links, 2020
- Why does COVID-19 disproportionately affect older people?Aging, 2020
- Rising to the Challenge of COVID-19: Advice for Pulmonary and Critical Care and an Agenda for ResearchAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysisAging, 2020
- Favipiravir versus Arbidol for COVID-19: A Randomized Clinical TrialmedRxiv, 2020
- A review on the role of Homoeopathy in epidemics with some reflections on COVID-19 (SARS-CoV-2)Indian Journal of Research in Homoeopathy, 2020
- Effect of Adjuvant Homeopathy with Usual Care in Management of Thrombocytopenia Due to Dengue: A Comparative Cohort StudyHomeopathy, 2019
- Comparitive evaluation of different systems of medicines and the present scenario of chikungunya in KeralaAsian Pacific Journal of Tropical Medicine, 2010